Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Argus Health
Medtronic
Fuji
Cerilliant
Chubb
Daiichi Sankyo
Moodys
Cipla
Johnson and Johnson

Generated: October 18, 2017

DrugPatentWatch Database Preview

Perrigo New York Company Profile

« Back to Dashboard

What is the competitive landscape for PERRIGO NEW YORK, and when can generic versions of PERRIGO NEW YORK drugs launch?

PERRIGO NEW YORK has sixty-one approved drugs.

There is one US patent protecting PERRIGO NEW YORK drugs.

There are five patent family members on PERRIGO NEW YORK drugs in five countries and seventeen supplementary protection certificates in nine countries.

Summary for Applicant: Perrigo New York

International Patents:5
US Patents:1
Tradenames:30
Ingredients:29
NDAs:61
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo New York
CENTANY
mupirocin
OINTMENT;TOPICAL050788-001Dec 4, 2002BXRXNoNo► Subscribe► SubscribeY ► Subscribe
Perrigo New York
CICLOPIROX
ciclopirox
CREAM;TOPICAL077364-001Mar 3, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Perrigo New York
PERMETHRIN
permethrin
LOTION;TOPICAL076090-001Dec 20, 2001OTCNoNo► Subscribe► Subscribe► Subscribe
Perrigo New York
TRIAMCINOLONE ACETONIDE
triamcinolone acetonide
CREAM;TOPICAL086413-001Approved Prior to Jan 1, 1982ATRXNoNo► Subscribe► Subscribe► Subscribe
Perrigo New York
FLUOCINOLONE ACETONIDE
fluocinolone acetonide
CREAM;TOPICAL086810-001Mar 4, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Perrigo New York
BETAMETHASONE VALERATE
betamethasone valerate
OINTMENT;TOPICAL071478-001Dec 23, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Perrigo New York
DESOXIMETASONE
desoximetasone
GEL;TOPICAL077552-001Jan 9, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Perrigo New York
CICLOPIROX
ciclopirox
SOLUTION;TOPICAL077623-001Sep 18, 2007ATRXNoNo► Subscribe► Subscribe► Subscribe
Perrigo New York
HYDROCORTISONE
hydrocortisone
LOTION;TOPICAL085663-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Perrigo New York
FLUOCINONIDE
fluocinonide
CREAM;TOPICAL071790-001Jul 13, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Perrigo New York Drugs

Country Document Number Estimated Expiration
Israel123143► Subscribe
Spain2165723► Subscribe
Germany69900561► Subscribe
Canada2259764► Subscribe
European Patent Office0933081► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Perrigo New York Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
00617Netherlands► SubscribePRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322
C/GB10/012United Kingdom► SubscribePRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112
80024Netherlands► SubscribePRODUCT NAME: GADOBEENZUUR,DESGEWENST IN DE VORM VAN EEN ZOUT MET EEN ALKA- LIMETAAL, AARDALKALIMETAAL, OF BASISCH GEPROTONEERD AMINOZUUR OF VAN EEN ALKYLAMMONIUM-, ALKANOLAMMONIUM- OF POLYHYDROXYAL- KYLAMMONIUMZOUT, IN HET BIJZONDER DIMEGLUMINI GADOBENAS; NAT. REGISTRATION NO/DATE: RVG 22324 19980706; FIRST REGISTRATION: GB PL 06099/0006 19970722
1304992/01Switzerland► SubscribePRODUCT NAME: CLINDAMYCINI PHOSPHAS ET TRETINOINUM; REGISTRATION NO/DATE: SWISSMEDIC 62513 28.03.2014
C0002Belgium► SubscribePRODUCT NAME: MOMETASONE FUROATE; NAT. REGISTRATION NO/DATE: NL 19601 19950919; FIRST REGISTRATION: GR - 10681/89 19900622
13/044Ireland► SubscribePRODUCT NAME: CLINDAMYCIN AND TRETINOIN; REGISTRATION NO/DATE: PA1332/043/001 20130322
2013 00053Denmark► SubscribePRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322
269Luxembourg► SubscribePRODUCT NAME: AZELASTINE,OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUICI,ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE
C0038France► SubscribePRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026
C/GB97/005United Kingdom► SubscribePRODUCT NAME: DOLASETRON, OR A PHARMACEUTICALLY-ACCEPTABLE ACID ADDITION OR QUATERNARY AMMONIUM SALT THEREOF; REGISTERED: UK 04425/0150 19960926
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
AstraZeneca
Citi
Queensland Health
Fish and Richardson
Colorcon
Dow
Farmers Insurance
Medtronic
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot